Biomedical Diagnostics CE marks test to tailor autoimmune disease treatment
This article was originally published in Clinica
Executive Summary
Autoimmune disease specialist Biomedical Diagnostics (Marne la Vallée, France) has CE marked its Lisa Tracker Premium test kit for sale in Europe. The diagnostic is designed to improve the management of autoimmune diseases such as rheumatoid arthritis and Crohn’s disease. It simultaneously measures levels of the cytokine tumour necrosis factor (TNF)-α, anti-TNF drugs, and neutralising anti-drug antibodies (ADAs). TNF-α is involved in inflammation and is often elevated in autoimmune disorders. TNF inhibitors such as infliximab and etanercept are less effective in patients who develop ADAs, who often experience a relapse of disease. Measuring these three parameters therefore helps physicians predict a patient’s response to these medications and tailor treatment accordingly.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.